Symbol Name ID |
Abhd5
abhydrolase domain containing 5 MGI:1914719 |
Darker colors indicate more annotations |
Human Phenotypes | Hepatic steatosis |
Hepatomegaly |
Micronodular cirrhosis |
Disease(s) Associated with ABHD5 | |||
Chanarin-Dorfman syndrome |
Mouse Phenotypes | enlarged liver |
increased liver weight |
increased liver cholesterol level |
increased liver free fatty acids level |
decreased liver triglyceride level |
increased liver triglyceride level |
liver inflammation |
abnormal liver morphology |
abnormal hepatocyte morphology |
hepatic steatosis |
macrovesicular hepatic steatosis |
microvesicular hepatic steatosis |
liver fibrosis |
pale liver |
abnormal liver physiology |
|
Availability | Mouse Genotype | |||||||||||||||
Abhd5tm1.1Rze/Abhd5tm1.1Rze | ||||||||||||||||
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ (conditional) |
||||||||||||||||
Abhd5tm1Rze/Abhd5tm1Rze Tg(Ckmm-cre)5Khn/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|